Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Facts about an implantable contraceptive: memorandum from a WHO meeting.

Literature DB >> 3930082

Facts about an implantable contraceptive: memorandum from a WHO meeting.

Abstract

This Memorandum reviews the results of research undertaken in animals and human subjects on the implantable contraceptive, Norplant, and where relevant, its components, levonorgestrel and Silastic. Results from clinical trials, including effectiveness and side-effects, are evaluated and service delivery aspects commented on. The Memorandum concludes with a statement regarding the use of Norplant as an option for long-term reversible contraception.

Entities: Chemical Species

Mesh：

Substances：

Year: 1985 PMID： 3930082 PMCID： PMC2536418

Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408

Keyword Cloud
References

31 in total

1. Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women.

Authors: H B Croxatto; S Díaz; E Quinteros; L Simoneti; E Kaplan; R Rencoret; P Leixelard; C Mártinez
Journal: Contraception Date: 1975-12 Impact factor: 3.375

2. Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.

Authors: E Weiner; E D Johansson
Journal: Contraception Date: 1976-07 Impact factor: 3.375

3. One-year contraception with norgestrienone subdermal silastic implants.

Authors: E M Coutinho; A R da Silva
Journal: Fertil Steril Date: 1974-02 Impact factor: 7.329

4. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules.

Authors: H Croxatto; S Díaz; R Vera; M Etchart; P Atria
Journal: Am J Obstet Gynecol Date: 1969-12-01 Impact factor: 8.661

5. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids.

Authors: M N El Makhzangy; V Wynn; D M Lawrence
Journal: Clin Endocrinol (Oxf) Date: 1979-01 Impact factor: 3.478

6. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.

Authors: D E Moore; S Roy; F Z Stanczyk; D R Mishell
Journal: Contraception Date: 1978-04 Impact factor: 3.375

7. Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.

Authors: M Hümpel; H Wendt; G Pommerenke; C Weiss; U Speck
Journal: Contraception Date: 1978-03 Impact factor: 3.375